LNH 87 protocol

chemotherapy protocol consisting of above compounds for treatment of aggressive non-Hodgkin's lymphoma; ACVBP is induction phase of LNH87

Also Known As:

ACVBP protocol; LNH87 protocol

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - LNH 87 protocol: 3
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - LNH 87 protocol: 3
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - LNH 87 protocol: 3
Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        LNH 87 protocol: 3
- Glycoconjugates: 1353
  - Glycopeptides: 1928
    - Bleomycin: 9833
      - LNH 87 protocol: 3
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Glycopeptides: 1928
    - Bleomycin: 9833
      - LNH 87 protocol: 3
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthacenes
        Anthracyclines: 9423
        Daunorubicin: 2641
        Doxorubicin: 35390
        LNH 87 protocol: 3
  - Halogenated Hydrocarbons: 42
    - Mustard Compounds: 3
      - Nitrogen Mustard Compounds: 2
        Phosphoramide Mustards: 5
        Cyclophosphamide: 25473
        LNH 87 protocol: 3
- Organophosphorus Compounds: 300
  - Phosphoramides: 8
    - Phosphoramide Mustards: 5
      - Cyclophosphamide: 25473
        LNH 87 protocol: 3
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthacenes
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        LNH 87 protocol: 3
- Fused-Ring Compounds
  - Steroids: 70059
    - Pregnanes: 9
      - Pregnadienes
        Pregnadienediols
        Prednisone: 12650
        LNH 87 protocol: 3
Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Indole Alkaloids: 200
    - Secologanin Tryptamine Alkaloids: 81
      - Vinca Alkaloids: 463
        Vindesine: 836
        LNH 87 protocol: 3
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        Vindesine: 836
        LNH 87 protocol: 3
    - Indolizines: 3
      - Indolizidines: 2
        Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        Vindesine: 836
        LNH 87 protocol: 3

Experts

1.	André, M: 1 article (03/2001)
2.	Berger, F: 1 article (03/2001)
3.	Bosly, A: 1 article (03/2001)
4.	Brière, J: 1 article (03/2001)
5.	Cazals-Hatem, D: 1 article (03/2001)
6.	Copin, M C: 1 article (03/2001)
7.	Diebold, J: 1 article (03/2001)
8.	Divine, M: 1 article (03/2001)
9.	Gaulard, P: 1 article (03/2001)
10.	Kerneis, Y: 1 article (03/2001)

Related Diseases

1.	Lymphoma (Lymphomas) 07/01/1998 - "From October 1987 to March 1993, 1,883 patients with diffuse aggressive non-Hodgkin's lymphomas (NHL) included in the LNH87 protocol could be assessed for both morphology and immunophenotyping. " 02/01/1998 - "Among 140 patients with positive skin biopsies included in the LNH87 protocol (for treatment of aggressive lymphomas), 49 patients met the criteria of PCLL. " 03/01/2001 - "Between 1987 and 1993, 77 of 2855 lymphomas included in the LNH87 protocol of the GELA as non-Hodgkin lymphoma (NHL) and reviewed by a panel of pathologists had a diagnosis changed to Hodgkin lymphoma (HL). "
2.	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/01/2001 - "Between 1987 and 1993, 77 of 2855 lymphomas included in the LNH87 protocol of the GELA as non-Hodgkin lymphoma (NHL) and reviewed by a panel of pathologists had a diagnosis changed to Hodgkin lymphoma (HL). "
3.	Hodgkin Disease (Hodgkin's Disease) 03/01/2001 - "Between 1987 and 1993, 77 of 2855 lymphomas included in the LNH87 protocol of the GELA as non-Hodgkin lymphoma (NHL) and reviewed by a panel of pathologists had a diagnosis changed to Hodgkin lymphoma (HL). "